MKI67 and neoplasm: In dataset A, changes in Ki67 reflected the primary endpoint results (objective decrease in tumor size), whereas changes in phosphorylated S6 were not correlated with clinical outcomes and seemed to indicate a purely pharmacodynamic effect [14].